BioWorld Asia

Dec. 13, 2006

View Archived Issues

Blindness Gene Identified In Chickens Could Have Impact

Novexel Licenses Aminocandin From Indevus Pharmaceuticals

Belgium's ThromboGenics In Novel Biotech Deal With India

Trophos Announces Plans For ALS TRO19622 Phase II/III Trial

Actelion Shares On Rise As Actelion-1 Now In Phase III

Peptech Ponders Various Ways Of Spending £71.3M

Genfit To List Shares On Alternext Market In Paris

PanGenetics In Deals With Schering-Plough, LayLine

Other News To Note

Newron Raises CHF118.12M In Swiss Initial Public Offering

Shares in Newron Pharmaceuticals SpA opened on the Swiss Stock Exchange in Zurich at CHF58 (US$48.20) Tuesday, more than 5 percent above its initial public offering price of CHF55 per share. (BioWorld International) Read More

Pharminox, Schering-Plough Enter Deal Worth Up To $40M

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...